Titulo:

Estrategias de Reperfusión en el tratamiento de la embolia pulmonar aguda: Una revisión narrativa de la literatura
.

Guardado en:

0121-5426

2538-9513

35

2023-06-01

34

45

Revista Colombiana de Neumología - 2023

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.

info:eu-repo/semantics/openAccess

http://purl.org/coar/access_right/c_abf2

id metarevistapublica_asoneumocito_revistacolombianadeneumologia_28-article-603
record_format ojs
institution ASOCIACION COLOMBIANA DE NEUMOLOGIA Y CIRUGIA DE TORAX
thumbnail https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADENEUMOLOGIAYCIRUGIADETORAX/logo.png
country_str Colombia
collection Revista Colombiana de Neumología
title Estrategias de Reperfusión en el tratamiento de la embolia pulmonar aguda: Una revisión narrativa de la literatura
spellingShingle Estrategias de Reperfusión en el tratamiento de la embolia pulmonar aguda: Una revisión narrativa de la literatura
Zarama Valenzuela, Alvaro
Villaquirán-Torres, Claudio
Celis-Preciado, Carlos Andrés
radiología intervencionista
terapia trombolítica
Thrombolytic Therapy
Therapeutics
Reperfusion
Interventional Radiology
reperfusión
terapéutica
embolia pulmonar
Pulmonary Embolism
title_short Estrategias de Reperfusión en el tratamiento de la embolia pulmonar aguda: Una revisión narrativa de la literatura
title_full Estrategias de Reperfusión en el tratamiento de la embolia pulmonar aguda: Una revisión narrativa de la literatura
title_fullStr Estrategias de Reperfusión en el tratamiento de la embolia pulmonar aguda: Una revisión narrativa de la literatura
title_full_unstemmed Estrategias de Reperfusión en el tratamiento de la embolia pulmonar aguda: Una revisión narrativa de la literatura
title_sort estrategias de reperfusión en el tratamiento de la embolia pulmonar aguda: una revisión narrativa de la literatura
author Zarama Valenzuela, Alvaro
Villaquirán-Torres, Claudio
Celis-Preciado, Carlos Andrés
author_facet Zarama Valenzuela, Alvaro
Villaquirán-Torres, Claudio
Celis-Preciado, Carlos Andrés
topic radiología intervencionista
terapia trombolítica
Thrombolytic Therapy
Therapeutics
Reperfusion
Interventional Radiology
reperfusión
terapéutica
embolia pulmonar
Pulmonary Embolism
topic_facet radiología intervencionista
terapia trombolítica
Thrombolytic Therapy
Therapeutics
Reperfusion
Interventional Radiology
reperfusión
terapéutica
embolia pulmonar
Pulmonary Embolism
citationvolume 35
citationissue 1
citationedition Núm. 1 , Año 2023 : .
publisher Asociación Colombiana de Neumología y Cirugía de Tórax
ispartofjournal Revista Colombiana de Neumología
source https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/603
language
format Article
rights Revista Colombiana de Neumología - 2023
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-sa/4.0
type_driver info:eu-repo/semantics/article
type_coar http://purl.org/coar/resource_type/c_6501
type_version info:eu-repo/semantics/publishedVersion
type_coarversion http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content Text
publishDate 2023-06-01
date_accessioned 2023-06-01 00:00:00
date_available 2023-06-01 00:00:00
url https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/603
url_doi https://doi.org/10.30789/rcneumologia.v35.n1.2023.603
issn 0121-5426
eissn 2538-9513
doi 10.30789/rcneumologia.v35.n1.2023.603
citationstartpage 34
citationendpage 45
url2_str_mv https://revistas.asoneumocito.org/index.php/rcneumologia/article/download/603/618
_version_ 1818394643942866944
spelling Estrategias de Reperfusión en el tratamiento de la embolia pulmonar aguda: Una revisión narrativa de la literatura
35
Zarama Valenzuela, Alvaro
Asociación Colombiana de Neumología y Cirugía de Tórax
Artículo de revista
Núm. 1 , Año 2023 : .
1
Revista Colombiana de Neumología
Villaquirán-Torres, Claudio
Celis-Preciado, Carlos Andrés
Journal article
info:eu-repo/semantics/article
Revista Colombiana de Neumología - 2023
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
34
45
Bĕlohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013;18(2):129–38. PMID: 23940438; PMCID: PMC3718593. 2. Dennis R, De Arboleda MN, Rodriguez MN, Salazar MS, Posada PS. Estudio nacional sobre tromboembolismo venoso en población hospitalaria en Colombia: Diferencias entre ciudades y especialidades. Acta Médica Colomb. 1996;21(2):55–63. ID: lil-183342. 3. Dennis R, Rojas MX, Molina Á, Roa J, Granados M, Londoño A, et al. Curso clínico y supervivencia en embolia pulmonar: Resultados del registro multicéntrico colombiano (EMEPCO). Acta Medica Colomb. 2008;33(3):111–6. ISSN 0120-2448. 4. Yamamoto T. Management of patients with high-risk pulmonary embolism: a narrative review. J Intensive Care. 2018;6:16. doi: 10.1186/s40560-018-0286-8. 5. Thabut G, Thabut D, Myers RP, Bernard-Chabert B, Marrash-Chahla R, Mal H, et al. Thrombolytic therapy of pulmonary embolism: a meta-analysis. J Am Coll Cardiol. 2002;40(9):1660–7. doi: 10.1016/s0735-1097(02)02381-1. 6. Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism: A Meta-Analysis of the Randomized Controlled Trials. Circulation. 2004;110(6):744–9. doi: 10.1161/01.CIR.0000137826.09715.9C. 7. Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, et al. Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism. N Engl J Med. 2014;370(15):1402–11. doi: 10.1056/NEJMoa1302097. 8. Goldhaber SZ. PEITHO Long-Term Outcomes Study. J Am Coll Cardiol. 2017;69(12):1545–8. doi: 10.1016/j.jacc.2017.01.027. 9. Chatterjee S, Chakraborty A, Weinberg I, Kadakia M, Wilensky RL, Sardar P, et al. Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage. JAMA. 2014;311(23):2414. doi: 10.1001/jama.2014.5990. 10. Marti C, John G, Konstantinides S, Combescure C, Sanchez O, Lankeit M, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2015;36(10):605–14. doi: 10.1093/eurheartj/ehu218. 11. Zuo Z, Yue J, Dong BR, Wu T, Liu GJ, Hao Q. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev. 2021;4(4):CD004437. doi: 10.1002/14651858.CD004437.pub6. 12. Izcovich A, Criniti JM, Popoff F, Lu L, Wu J, Ageno W et al. Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis. Blood Adv. 2020;4(7):1539-1553. doi: 10.1182/bloodadvances.2020001513. 13. Hao Q, Dong BR, Yue J, Wu T, Liu GJ. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev. 2015;(9):CD004437. doi: 10.1002/14651858.CD004437.pub4. 14. Xu Q, Huang K, Zhai Z, Yang Y, Wang J, Wang C. Initial thrombolysis treatment compared with anticoagulation for acute intermediate-risk pulmonary embolism: a meta-analysis. J Thorac Dis. 2015;7(5):810–21. doi: 10.3978/j.issn.2072-1439.2015.04.51. 15. Gao G, Yang P, Liu M, Ding M, Liu G, Tong Y, et al. Thrombolysis for acute intermediate-risk pulmonary embolism: A meta-analysis. Thromb Res. 2015;136(5):932–7. doi: 10.1016/j.thromres.2015.09.012. 16. Cao J, Cao Y, Chen H, Gao W, Wang Y. Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism. Patient Prefer Adherence. 2014;8:275. doi: 10.2147/PPA.S56280. 17. Liu Y, Lu Y, Song J, Li D, Liu H, Yang J, et al. Recombinant tissue plasminogen activator for hemodynamically stable patients experiencing an acute pulmonary embolism: A meta-analysis. Thromb Res. 2014;134(1):50–6. doi: 10.1016/j.thromres.2014.04.007. 18. Nakamura S, Takano H, Kubota Y, Asai K, Shimizu W. Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis. J Thromb Haemost. 2014;12(7):1086–95. doi: 10.1111/jth.12608. 19. Riera-Mestre A, Becattini C, Giustozzi M, Agnelli G. Thrombolysis in hemodynamically stable patients with acute pulmonary embolism: A meta-analysis. Thromb Res. 2014;134(6):1265–71. doi: 10.1016/j.thromres.2014.10.004. 20. Zhang Z, Zhai Z, Liang L, Liu F, Yang Y, Wang C. Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: A systematic review and meta-analysis. Thromb Res. 2014;133(3):357–63. doi: 10.1016/j.thromres.2013.12.026. 21. Chen H, Ren C, Chen H. Thrombolysis Versus Anticoagulation for the Initial Treatment of Moderate Pulmonary Embolism: A Meta-Analysis of Randomized Controlled Trials. Respir Care. 2014;59(12):1880–7. doi: 10.4187/respcare.03197. 22. Wang T-F, Squizzato A, Dentali F, Ageno W. The role of thrombolytic therapy in pulmonary embolism. Blood. 2015;125(14):2191–9. doi: 10.1182/blood-2014-08-559278. 23. Naidu SG, Knuttinen M-G, Kriegshauser JS, Eversman WG, Oklu R. Rationale for catheter directed therapy in pulmonary embolism. Cardiovasc Diagn Ther. 2017;7(Suppl 3):S320–8. doi: 10.21037/cdt.2017.08.14. 24. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing G-J, Harjola V-P et al. 2019 ESC guidelines on the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543–603. doi: 10.1093/eurheartj/ehz405. 25. Fiumara K, Kucher N, Fanikos J, Goldhaber SZ. Predictors of Major Hemorrhage Following Fibrinolysis for Acute Pulmonary Embolism. Am J Cardiol. 2006;97(1):127–9. doi: 10.1016/j.amjcard.2005.07.117. 26. Chatterjee S, Weinberg I, Yeh RW, Chakraborty A, Sardar P, Weinberg MD, et al. Risk factors for intracranial haemorrhage in patients with pulmonary embolism treated with thrombolytic therapy Development of the PE-CH Score. Thromb Haemost. 2017;117(02):246–51. doi: 10.1160/TH16-07-0588. 27. Daniels LB, Parker JA, Patel SR, Grodstein F, Goldhaber SZ. Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol. 1997;80(2):184–8. doi: 10.1016/s0002-9149(97)00315-9. 28. Wang C, Zhai Z, Yang Y, Wu Q, Cheng Z, Liang L, et al. Efficacy and Safety of Low Dose Recombinant Tissue-Type Plasminogen Activator for the Treatment of Acute Pulmonary Thromboembolism. Chest. 2010;137(2):254–62. doi: 10.1378/chest.09-0765. 29. Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M. Moderate Pulmonary Embolism Treated With Thrombolysis (from the “MOPETT” Trial). Am J Cardiol. Excerpta Medica. 2013;111(2):273–7. doi: 10.1016/j.amjcard.2012.09.027. 30. Sanchez O, Charles-Nelson A, Ageno W, Barco S, Binder H, Chatellier G et al. Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-Risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial. Thromb Haemost. 2022;122(5):857-866. 31. Kuo WT, Gould MK, Louie JD, Rosenberg JK, Sze DY, Hofmann L V. Catheter-directed Therapy for the Treatment of Massive Pulmonary Embolism: Systematic Review and Meta-analysis of Modern Techniques. J Vasc Interv Radiol. 2009;20(11):1431–40. doi: 10.1016/j.jvir.2009.08.002. 32. Avgerinos ED, Saadeddin Z, Abou Ali AN, Fish L, Toma C, Chaer M, et al. A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism. J Vasc Surg Venous Lymphat Disord. 2018;6(4):530–40. doi: 10.1016/j.jvsv.2018.03.010. 33. Kaymaz C, Akbal OY, Tanboga IH, Hakgor A, Yilmaz F, Ozturk S et al. Ultrasound-Assisted Catheter-Directed Thrombolysis in High-Risk and Intermediate-High-Risk Pulmonary Embolism: A Meta-Analysis. Curr Vasc Pharmacol. 2018;16(2):179-189. doi: 10.2174/1570161115666170404122535. 34. Pei DT, Liu J, Yaqoob M, Ahmad W, Bandeali SS, Hamzeh IR et al. Meta-analysis of Catheter Directed Ultrasound-Assisted Thrombolysis in Pulmonary Embolism. Am J Cardiol. 2019;124(9):1470-1477. doi: 10.1016/j.amjcard.2019.07.040. 35. Wu J, Chen H, Yu Y, Peng L, Li J, Liang H et al. Feasability of ultrasound-assisted catheter-directed thrombolysis for submassive pulmonary embolism: A meta-analysis of case series. Clin Respir J. 2020;14(5):430-439. doi: 10.1111/crj.13155. 36. EKOS Corporation. EkoSonic MACH4 Endovascular Device Instructions for Use. EKOS corporation [s.f.]. Disponible en: https://www.btg-im.com/BTG/media/EKOS-Files/EKOS%20Instructions%20For%20Use/6998_B_IFU-EkoSonic-MACH4-PE-Peripheral.pdf 37. Aggarwal V, Nicolais CD, Lee A, Bashir R. Acute Management of Pulmonary Embolism (Internet). American College of Cardiology. 2017. Disponible en: https://www.acc.org/latest-in-cardiology/articles/2017/10/23/12/12/acute-management-of-pulmonary-embolism. 38. Piazza G, Goldhaber SZ. Management of submassive pulmonary embolism. Circulation. 2010;122(11):1124–9. doi: 10.1161/CIRCULATIONAHA.110.961136 39. Jimenez D, Martin-Saborido C, Muriel A, Zamora J, Morillo R, Barrios D, et al. Efficacy and safety outcomes of recanalisation procedures in patients with acute symptomatic pulmonary embolism: systematic review and network meta-analysis. Thorax. 2018;73:464-471. doi: 10.1136/thoraxjnl-2017-210040. 40. Pasha AK, Siddiqui MU, Siddiqui MD, Ahmed A, Abdullah A, Riaz I et al. Catheter directed compared to systematically delivered thrombolysis for pulmonary embolus: a systematic review and meta-analysis. J Thromb Thrombolysis. 2021;53:454-466. doi: 10.1007/s11239-021-02556-7. 41. Siordia JA, Kaur A. Catheter-Directed Thrombolysis versus Systemic Anticoagulation for Submassive Pulmonary Embolism: A Meta-Analysis. Curr Cardiol Rev. 2021;18(1):112-117. doi: 10.2174/1573403X17666210603114116. 42. Avgerinos ED, Jaber W, Lacomis J, Markel J, McDaniel M, Rivera-Lebron BN et al. Randomized Trial Comparing Standard Versus Ultrasound Thrombolysis for Submassive Pulmonary Embolism. JACC Cardiovasc Interv. 2021;14(12):1364-1373. doi: 10.1016/j.jcin.2021.04.049. 43. Dudzinski DM, Piazza G. Multidisciplinary Pulmonary Embolism Response Teams. Circulation. 2016;133(1):98–103. doi: 10.1161/CIRCULATIONAHA.115.015086. 44. Rodriguez-Lopez J, Channick R. The Pulmonary Embolism Response Team: What Is the Ideal Model? Semin Respir Crit Care Med. 2017;38(01):051–5. doi: 10.1055/s-0036-1597561.
https://revistas.asoneumocito.org/index.php/rcneumologia/article/download/603/618
radiología intervencionista
http://purl.org/coar/resource_type/c_6501
http://purl.org/coar/resource_type/c_dcae04bc
http://purl.org/redcol/resource_type/ARTREV
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/version/c_970fb48d4fbd8a85
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
Text
https://creativecommons.org/licenses/by-nc-sa/4.0
10.30789/rcneumologia.v35.n1.2023.603
https://doi.org/10.30789/rcneumologia.v35.n1.2023.603
terapia trombolítica
Thrombolytic Therapy
Therapeutics
Reperfusion
Interventional Radiology
reperfusión
terapéutica
embolia pulmonar
Pulmonary Embolism
2023-06-01 00:00:00
2023-06-01 00:00:00
2023-06-01
application/pdf
0121-5426
2538-9513
https://revistas.asoneumocito.org/index.php/rcneumologia/article/view/603
Publication